Cargando…

QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases

BACKGROUND: Histamine H(3) receptor (H(3)R) is associated with several neuropsychological diseases, and thus it is an important target involved in several CNS disorders, such as narcolepsy, attention deficit hyperactivity disorder and schizophrenia. Since QSAR modeling is a feasible approach to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrêa, Michelle Fidelis, Fernandes, João Paulo dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080103/
https://www.ncbi.nlm.nih.gov/pubmed/28820054
http://dx.doi.org/10.2174/1570159X15666170818100644
_version_ 1783345413708840960
author Corrêa, Michelle Fidelis
Fernandes, João Paulo dos Santos
author_facet Corrêa, Michelle Fidelis
Fernandes, João Paulo dos Santos
author_sort Corrêa, Michelle Fidelis
collection PubMed
description BACKGROUND: Histamine H(3) receptor (H(3)R) is associated with several neuropsychological diseases, and thus it is an important target involved in several CNS disorders, such as narcolepsy, attention deficit hyperactivity disorder and schizophrenia. Since QSAR modeling is a feasible approach to explain the role of the molecular substituents in the biological activity, it can help in improving the design of better H(3)R ligands for these conditions. METHODS: This article reviews papers previously published in literature to show the current status of the contribution from QSAR modeling to reach H(3)R antagonists/inverse agonists. RESULTS: Classical and 3D-QSAR models were retrieved, showing that the steric and hydrophobic properties of the H(3)R ligands are most important to reach good affinity. CONCLUSION: Although QSAR methods are valuable to design better H(3)R antagonists/inverse agonists, pharmacokinetics should also be considered in future models to ensure good CNS penetration.
format Online
Article
Text
id pubmed-6080103
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-60801032019-01-01 QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases Corrêa, Michelle Fidelis Fernandes, João Paulo dos Santos Curr Neuropharmacol Article BACKGROUND: Histamine H(3) receptor (H(3)R) is associated with several neuropsychological diseases, and thus it is an important target involved in several CNS disorders, such as narcolepsy, attention deficit hyperactivity disorder and schizophrenia. Since QSAR modeling is a feasible approach to explain the role of the molecular substituents in the biological activity, it can help in improving the design of better H(3)R ligands for these conditions. METHODS: This article reviews papers previously published in literature to show the current status of the contribution from QSAR modeling to reach H(3)R antagonists/inverse agonists. RESULTS: Classical and 3D-QSAR models were retrieved, showing that the steric and hydrophobic properties of the H(3)R ligands are most important to reach good affinity. CONCLUSION: Although QSAR methods are valuable to design better H(3)R antagonists/inverse agonists, pharmacokinetics should also be considered in future models to ensure good CNS penetration. Bentham Science Publishers 2018-07 2018-07 /pmc/articles/PMC6080103/ /pubmed/28820054 http://dx.doi.org/10.2174/1570159X15666170818100644 Text en © 2018 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Corrêa, Michelle Fidelis
Fernandes, João Paulo dos Santos
QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title_full QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title_fullStr QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title_full_unstemmed QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title_short QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
title_sort qsar modeling of histamine h(3)r antagonists/inverse agonists as future drugs for neurodegenerative diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080103/
https://www.ncbi.nlm.nih.gov/pubmed/28820054
http://dx.doi.org/10.2174/1570159X15666170818100644
work_keys_str_mv AT correamichellefidelis qsarmodelingofhistamineh3rantagonistsinverseagonistsasfuturedrugsforneurodegenerativediseases
AT fernandesjoaopaulodossantos qsarmodelingofhistamineh3rantagonistsinverseagonistsasfuturedrugsforneurodegenerativediseases